Per the claim, products that contain a daily serving of 500mg whole fruit cranberry may now claim to reduce risk of urinary tract infections on their labels and in their marketing materials. “The FDA ruling does not include cranberry powders made with juice concentrate,” notes Fruit d’Or Lead Consultant Stephen Lukawski in the press release. “It specifies only whole fruit cranberry.”
Softgels and gummies are easier to swallow or chew as compared to capsules or tablets, the press release states, but there are formulation concerns, according to Lukawski, who explains that fibers in softgels can cause leakage. “The 80-mesh particle size enables Fruit d’Or whole fruit cranberry powder to be used in softgels without concerns about leakage caused by fibers. We now offer 40-, 60- and 80-mesh which opens opportunities to multiple delivery systems. As always, soluble and insoluble PACs are consistently analyzed to maintain our quality guarantee. Formulators can also blend our standardized whole fruit cranberry 80-mesh powder with other science-based women’s health ingredients (like D-Mannose, for instance), both water- and oil-soluble. Ingredients that previously couldn’t go together are now compatible.”
Related: Fruit d’Or Educates on Cranberry Qualified Health Claim Fruit d’Or Discusses Efforts to Educate on Whole Fruit Cranberry Powder FDA Allows Health Claim for Magnesium & Blood Pressure
This could make a real difference to brands looking to use the Qualified Health Claim, according to Jean Leclerc, Director of Sales and Business Development for Fruit d’Or: “Being able to put 500 mg of whole fruit cranberry into softgels or gummies opens the doors for numerous women’s health formulas which, until now, haven’t been able to take advantage of the FDA health claim using their existing softgel formats. They can now switch from unstandardized cranberry juice powders to whole fruit cranberry powder without having to change their delivery vehicle.”
